Literature DB >> 9458162

A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.

A Waha1, M Watzka, A Koch, T Pietsch, R Przkora, N Peters, O D Wiestler, A von Deimling.   

Abstract

The specific analysis of gene transcripts is of increasing importance for studies in molecular pathology. Competitive RT-PCR with mutagenized exogenous competitor templates has evolved as an attractive approach to quantify individual mRNA levels. The generation of exogenous competitor RNAs usually requires mutagenesis and cloning of the mutant fragment into plasmids followed by in vitro transcription. In contrast to primer directed mutagenesis and in vitro transcription, preparation of the mutant fragments is a time consuming procedure. Here we report on a modified semi-quantitative RT-PCR protocol to circumvent the laborious cloning of mutant exogenous competitors. Templates for the in vitro transcription are generated in a single PCR reaction with simultaneous addition of a promoter sequence 5'of the forward primer and deletion of 10-20 nucleotides at the opposite end just ahead of the reverse primer binding site. The product of this PCR step serves as template for in vitro transcription to yield exogenous competitor RNA of equal quality and amount as conventional cloning strategies. Total RNA amounts are corrected for by analyzing the expression of different housekeeping genes in the same manner. One of the primers used in the following competitive RT-PCR reaction is labeled with a fluorescent dye for the analysis of target and exogenous competitor product on an semiautomated sequencer. In the present study, this protocol was employed to analyze the expression of the PTCH, Fas-receptor, NF-1, beta2-microglobulin and GAPD genes in human brain tumors. It will, however, be widely applicable to studies on cellular transcripts in biological specimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458162     DOI: 10.1111/j.1750-3639.1998.tb00129.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.

Authors:  W Hartmann; A Waha; A Koch; C G Goodyer; S Albrecht; D von Schweinitz; T Pietsch
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Heme oxygenase-1 expression in premature and mature neonates during the first week of life.

Authors:  Zoltán Maróti; Márta Katona; Hajnalka Orvos; Ilona Németh; Ildikó Farkas; Sándor Túri
Journal:  Eur J Pediatr       Date:  2007-01-04       Impact factor: 3.183

3.  Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.

Authors:  Valentina Vladimirova; Thomas Mikeska; Andreas Waha; Niels Soerensen; Jingying Xu; Patrick C Reynolds; Torsten Pietsch
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas.

Authors:  Anke Waha; Stefanie Güntner; Tim Hui-Ming Huang; Pearlly S Yan; Bülent Arslan; Torsten Pietsch; Otmar D Wiestler; Andreas Waha
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

5.  Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells.

Authors:  Wolfgang Hartmann; Arend Koch; Hendrik Brune; Anke Waha; Ulrich Schüller; Indra Dani; Dorota Denkhaus; Wilhelma Langmann; Udo Bode; Otmar D Wiestler; Karl Schilling; Torsten Pietsch
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

6.  p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.

Authors:  Marco Gessi; André O von Bueren; Stefan Rutkowski; Torsten Pietsch
Journal:  J Neurooncol       Date:  2011-07-28       Impact factor: 4.130

7.  Heme oxygenase 1 expression in young uremic patients on hemodialysis.

Authors:  Zoltán Maróti; Ilona Németh; Sándor Túri; Eszter Karg; Péter Ugocsai; Emoke Endreffy
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

8.  Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.

Authors:  Steven C Clifford; Birgitta Lannering; Ed C Schwalbe; Debbie Hicks; Kieran O'Toole; Sarah Leigh Nicholson; Tobias Goschzik; Anja Zur Mühlen; Dominique Figarella-Branger; François Doz; Stefan Rutkowski; Göran Gustafsson; Torsten Pietsch
Journal:  Oncotarget       Date:  2015-11-17

9.  Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells.

Authors:  Alexander Glassmann; Sabine Molly; Lachezar Surchev; Tommy A Nazwar; Martin Holst; Wolfgang Hartmann; Stephan L Baader; John Oberdick; Torsten Pietsch; Karl Schilling
Journal:  BMC Dev Biol       Date:  2007-10-09       Impact factor: 1.978

10.  HPASubC: A suite of tools for user subclassification of human protein atlas tissue images.

Authors:  Toby C Cornish; Aravinda Chakravarti; Ashish Kapoor; Marc K Halushka
Journal:  J Pathol Inform       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.